Marex has been for sale for several years as its PE owners sought an exit from their investment.
IPOs & Markets
The IPO priced at $6.25, at the low end of its $6.25 to $8.25 target price range, will value NIO at $6.4 billion
There are plenty of opportunities in the overseas markets, but we have a very good customer base in China... We would like to be rooted in China and f
Maoyan Weying was valued at $2.9 billion in November last year when it raised 1 billion yuan from Chinese internet giant Tencent Holdings.
Fosun reorganised its businesses in 2016, creating Fosun Tourism Group and paving the way for the latter's listing plan.
Meituan was valued at around $30 billion in a fundraising round late last year.
At least 10 more mostly Chinese biotechs plan to go public in the city this year, with some even dropping plans for U.S. share sales in favour of lis
Canaan and Ebang filed plans for floats in Hong Kong, while Bitmain is expected to file its plans next month to raise at least $3 billion
The biopharmaceutical firm raised $172 million from its Nasdaq IPO in September 2017.
The company is the world's second largest lithium producer by sales.
© Copyright DEALSTREETASIA 2014-2019 All rights reserved.
Forgot your password?
We will never share your information with third parties.
Already have an account? Sign in here
If you don’t already have an account click the button below to create your account.